BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 27731647)

  • 61. The emerging roles of human trace amines and human trace amine-associated receptors (hTAARs) in central nervous system.
    Khan MZ; Nawaz W
    Biomed Pharmacother; 2016 Oct; 83():439-449. PubMed ID: 27424325
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Design and synthesis of 1H-pyrazolo[3,4-c]pyridine derivatives as a novel structural class of potent GPR119 agonists.
    Matsuda D; Kobashi Y; Mikami A; Kawamura M; Shiozawa F; Kawabe K; Hamada M; Oda K; Nishimoto S; Kimura K; Miyoshi M; Takayama N; Kakinuma H; Ohtake N
    Bioorg Med Chem Lett; 2016 Aug; 26(15):3441-6. PubMed ID: 27390068
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Discovery of novel pyrimidine and malonamide derivatives as TGR5 agonists.
    Park EJ; Ahn YG; Jung SH; Bang HJ; Kim M; Hong DJ; Kim J; Suh KH; Kim YJ; Kim D; Kim EY; Lee K; Min KH
    Bioorg Med Chem Lett; 2014 Sep; 24(17):4271-5. PubMed ID: 25082126
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Synthesis and structure-activity relationship of the first nonpeptidergic inverse agonists for the human cytomegalovirus encoded chemokine receptor US28.
    Hulshof JW; Casarosa P; Menge WM; Kuusisto LM; van der Goot H; Smit MJ; de Esch IJ; Leurs R
    J Med Chem; 2005 Oct; 48(20):6461-71. PubMed ID: 16190772
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Synthesis and SAR studies of bicyclic amine series GPR119 agonists.
    Sakairi M; Kogami M; Torii M; Kataoka H; Fujieda H; Makino M; Kataoka D; Okamoto R; Miyazawa T; Okabe M; Inoue M; Takahashi N; Harada S; Watanabe N
    Bioorg Med Chem Lett; 2012 Aug; 22(15):5123-8. PubMed ID: 22765901
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Interaction analyses of hTAAR1 and mTAAR1 with antagonist EPPTB.
    Liao S; Pino MJ; Deleon C; Lindner-Jackson M; Wu C
    Life Sci; 2022 Jul; 300():120553. PubMed ID: 35452636
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Trace amine-associated receptor 1-Family archetype or iconoclast?
    Grandy DK
    Pharmacol Ther; 2007 Dec; 116(3):355-90. PubMed ID: 17888514
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The Case for TAAR1 as a Modulator of Central Nervous System Function.
    Rutigliano G; Accorroni A; Zucchi R
    Front Pharmacol; 2017; 8():987. PubMed ID: 29375386
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The Multitarget Ligand 3-Iodothyronamine Modulates β-Adrenergic Receptor 2 Signaling.
    Dinter J; Khajavi N; Mühlhaus J; Wienchol CL; Cöster M; Hermsdorf T; Stäubert C; Köhrle J; Schöneberg T; Kleinau G; Mergler S; Biebermann H
    Eur Thyroid J; 2015 Sep; 4(Suppl 1):21-9. PubMed ID: 26601070
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A new perspective for schizophrenia: TAAR1 agonists reveal antipsychotic- and antidepressant-like activity, improve cognition and control body weight.
    Revel FG; Moreau JL; Pouzet B; Mory R; Bradaia A; Buchy D; Metzler V; Chaboz S; Groebke Zbinden K; Galley G; Norcross RD; Tuerck D; Bruns A; Morairty SR; Kilduff TS; Wallace TL; Risterucci C; Wettstein JG; Hoener MC
    Mol Psychiatry; 2013 May; 18(5):543-56. PubMed ID: 22641180
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Opportunities and challenges in the design of selective TAAR1 agonists: an editorial.
    Cichero E
    Expert Opin Ther Pat; 2018 Jun; 28(6):437-440. PubMed ID: 29757039
    [No Abstract]   [Full Text] [Related]  

  • 72. Discovery of Guanfacine as a Novel TAAR1 Agonist: A Combination Strategy through Molecular Modeling Studies and Biological Assays.
    Cichero E; Francesconi V; Casini B; Casale M; Kanov E; Gerasimov AS; Sukhanov I; Savchenko A; Espinoza S; Gainetdinov RR; Tonelli M
    Pharmaceuticals (Basel); 2023 Nov; 16(11):. PubMed ID: 38004497
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Trace amine-associated receptor 1 (TAAR1) is activated by amiodarone metabolites.
    Snead AN; Miyakawa M; Tan ES; Scanlan TS
    Bioorg Med Chem Lett; 2008 Nov; 18(22):5920-2. PubMed ID: 18752950
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Taar1-mediated modulation of presynaptic dopaminergic neurotransmission: role of D2 dopamine autoreceptors.
    Leo D; Mus L; Espinoza S; Hoener MC; Sotnikova TD; Gainetdinov RR
    Neuropharmacology; 2014 Jun; 81():283-91. PubMed ID: 24565640
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Structure-Activity Relationship Studies of Coumarin-like Diacid Derivatives as Human G Protein-Coupled Receptor-35 (hGPR35) Agonists and a Consequent New Design Principle.
    Wei L; Hou T; Li J; Zhang X; Zhou H; Wang Z; Cheng J; Xiang K; Wang J; Zhao Y; Liang X
    J Med Chem; 2021 Mar; 64(5):2634-2647. PubMed ID: 33630609
    [TBL] [Abstract][Full Text] [Related]  

  • 76. 3-Iodothyronamine Induces Diverse Signaling Effects at Different Aminergic and Non-Aminergic G-Protein Coupled Receptors.
    Biebermann H; Kleinau G
    Exp Clin Endocrinol Diabetes; 2020 Jun; 128(6-07):395-400. PubMed ID: 31698479
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The Action of TAAR1 Agonist RO5263397 on Executive Functions in Rats.
    Dorotenko A; Tur M; Dolgorukova A; Bortnikov N; Belozertseva IV; Zvartau EE; Gainetdinov RR; Sukhanov I
    Cell Mol Neurobiol; 2020 Mar; 40(2):215-228. PubMed ID: 31734895
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Design, synthesis, molecular docking and cytotoxic evaluation of novel 2-furybenzimidazoles as VEGFR-2 inhibitors.
    Abdullaziz MA; Abdel-Mohsen HT; El Kerdawy AM; Ragab FAF; Ali MM; Abu-Bakr SM; Girgis AS; El Diwani HI
    Eur J Med Chem; 2017 Aug; 136():315-329. PubMed ID: 28505536
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Synthesis and structure-activity relationships of a series of 3-aryl-4-isoxazolecarboxamides as a new class of TGR5 agonists.
    Budzik BW; Evans KA; Wisnoski DD; Jin J; Rivero RA; Szewczyk GR; Jayawickreme C; Moncol DL; Yu H
    Bioorg Med Chem Lett; 2010 Feb; 20(4):1363-7. PubMed ID: 20097073
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Design, synthesis, and biological evaluation of potent dual agonists of nuclear and membrane bile acid receptors.
    D'Amore C; Di Leva FS; Sepe V; Renga B; Del Gaudio C; D'Auria MV; Zampella A; Fiorucci S; Limongelli V
    J Med Chem; 2014 Feb; 57(3):937-54. PubMed ID: 24387325
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.